SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/5923DBE069EB182EFF1F8C1A05381EA2A3BC2606B02A7790935B4986BB131CE3B9D7A68502AA132F85F3386588061B85>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/5923DBE069EB182EFF1F8C1A05381EA2A3BC2606B02A7790935B4986BB131CE3B9D7A68502AA132F85F3386588061B85
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/5923DBE069EB182EFF1F8C1A05381EA2A3BC2606B02A7790935B4986BB131CE3B9D7A68502AA132F85F3386588061B85
http://www.w3.org/2000/01/rdf-schema#comment
"To study HLA-linked adverse drug reactions in vivo we generated HLA-B*57:01-Tg mice and show that although abacavir activated Tg mouse CD8+ T cells in vitro in a HLA-B*57:01-dependent manner the drug was tolerated in vivo."
xsd:string
http://purl.uniprot.org/uniprot/#_711DE47D47EF73A94F0C473359187818C52C873B06B6760AE5DBF9492C07F212CD137D4427104363B2A108B1B4711289
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/5923DBE069EB182EFF1F8C1A05381EA2A3BC2606B02A7790935B4986BB131CE3B9D7A68502AA132F85F3386588061B85
http://purl.uniprot.org/uniprot/D3JWR9
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/5923DBE069EB182EFF1F8C1A05381EA2A3BC2606B02A7790935B4986BB131CE3B9D7A68502AA132F85F3386588061B85
http://purl.uniprot.org/uniprot/#_D3JWR9-mappedCitation-29782330
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/5923DBE069EB182EFF1F8C1A05381EA2A3BC2606B02A7790935B4986BB131CE3B9D7A68502AA132F85F3386588061B85